These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6198954)

  • 41. Direct evidence that the gene product of the human chromosome 21 locus, IFRC, is the interferon-alpha receptor.
    Epstein CJ; McManus NH; Epstein LB; Branca AA; D'Alessandro SB; Baglioni C
    Biochem Biophys Res Commun; 1982 Aug; 107(3):1060-6. PubMed ID: 6182879
    [No Abstract]   [Full Text] [Related]  

  • 42. Interferon receptors.
    Langer JA; Pestka S
    Immunol Today; 1988 Dec; 9(12):393-400. PubMed ID: 2475121
    [No Abstract]   [Full Text] [Related]  

  • 43. [Receptor system for interferon].
    Yonehara S
    Seikagaku; 1984 Mar; 56(3):184-92. PubMed ID: 6205106
    [No Abstract]   [Full Text] [Related]  

  • 44. Nogo to IFN by Ras.
    Shmulevitz M; Mohamed A
    Cell Cycle; 2015 Aug; 14(15):2392-3. PubMed ID: 26103007
    [No Abstract]   [Full Text] [Related]  

  • 45. Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer.
    Escher TE; Dandawate P; Sayed A; Hagan CR; Anant S; Lewis-Wambi J
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human recombinant interferon-beta SER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse.
    Gibson DF; Johnson DA; Goldstein D; Langan-Fahey SM; Borden EC; Jordan VC
    Breast Cancer Res Treat; 1993; 25(2):141-50. PubMed ID: 8347846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Megestrol acetate plus alpha 2a interferon as second line therapy for postmenopausal patients with advanced breast cancer: results of a multicentric phase II trial.
    Amoroso D; Boccardo F; Balestrero M; Miglietta L; Brema F; Cellerino R; Farris A; Folco U; Iacobelli S; Mesiti M
    Breast Cancer Res Treat; 1995 Mar; 33(3):265-8. PubMed ID: 7749154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitizes them to the anti-proliferative effects of tamoxifen.
    van den Berg HW; Leahey WJ; Lynch M; Clarke R; Nelson J
    Br J Cancer; 1987 Mar; 55(3):255-7. PubMed ID: 3567059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase II trial of recombinant beta (IFN-betaser) interferon in the treatment of metastatic breast cancer.
    Barreras L; Vogel CL; Koch G; Marcus SG
    Invest New Drugs; 1988 Sep; 6(3):211-5. PubMed ID: 3192387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rationale for combining tamoxifen and interferon in the treatment of advanced breast cancer.
    Porzsolt F; Otto AM; Trauschel B; Buck C; Wawer AW; Schönenberger H
    J Cancer Res Clin Oncol; 1989; 115(5):465-9. PubMed ID: 2478560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interferons: current status and future directions of this prototypic biological.
    Smalley RV; Borden EC
    Springer Semin Immunopathol; 1986; 9(1):73-83. PubMed ID: 2425443
    [No Abstract]   [Full Text] [Related]  

  • 52. Biochemical and immunological responses of hairy cell leukemia patients to interferon beta.
    Liberati AM; Horisberger M; Schippa M; Di Clemente F; Fizzotti M; Filippo S; Proietti MG; Arzano S; Berruto P; Palmisano L
    Cancer Immunol Immunother; 1991; 34(2):115-22. PubMed ID: 1760815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.
    Macheledt JE; Buzdar AU; Hortobagyi GN; Frye DK; Gutterman JU; Holmes FA
    Breast Cancer Res Treat; 1991 Aug; 18(3):165-70. PubMed ID: 1756259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant human interferon-alpha 2a increases hormone receptor level of a human breast carcinoma xenograft in nude mice and enhances the anti-proliferative activity of tamoxifen.
    Josui K; Kubota T; Kitajima M
    Jpn J Cancer Res; 1992 Dec; 83(12):1347-53. PubMed ID: 1483948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of sex steroid receptors in obstetrics and gynecology.
    Roberts DK; Van Sickle M; Kelly RW
    Obstet Gynecol Annu; 1983; 12():61-78. PubMed ID: 6866353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
    Murphy LJ; Murphy LC; Vrhovsek E; Sutherland RL; Lazarus L
    Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of liposome-encapsulated alpha- or beta-interferon on breast cancer cell lines.
    Coradini D; Pellizzaro C; Biffi A; Lombardi L; Pirronello E; Riva L; Di Fronzo G
    Anticancer Res; 1998; 18(1A):177-82. PubMed ID: 9568074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interferon is a polypeptide hormone.
    Faltynek CR; Baglioni C
    Microbiol Sci; 1984 Jul; 1(4):81-5. PubMed ID: 6086078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interferon as a modifier of estrogen receptors.
    Dimitrov NV; Meyer CJ; Strander H; Einhorn S; Cantell K
    Ann Clin Lab Sci; 1984; 14(1):32-9. PubMed ID: 6198954
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.